When was Esteve founded?

Esteve was founded in 1929 and raised its 1st funding round 94 years after it was founded.

Where is Esteve located?

Esteve is headquartered in Barcelona, Spain.

Who is the current CEO of Esteve?

Marette Jean Francois of Esteve.

How many employees does Esteve have?

As of Sep 30, 2026, the latest employee count at Esteve is 2461.

Is Esteve a funded company?

Esteve is a funded company, having raised a total of $***** in its 1st and only funding round, a PE round on May 17, 2023.

When was the latest funding round of Esteve?

Esteve's latest funding was a $***** PE round on May 17, 2023, with participation from 0 investor.

Where does Esteve rank among its competitors?

Esteve ranks 99th amongst 1239 active competitors, of which 43 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Laboratorio Reig Jofre, which secured $14.7M in May, 2025.

Who are the top competitors of Esteve?

Esteve's top competitors include Bayer, Teva Pharmaceuticals and Wockhardt. Among them, Laboratorio Reig Jofre secured the most recent funding round in May, 2025.

Esteve - 2026 Company Profile, Team, Funding & Competitors

Esteve is a late stage company based in Barcelona (Spain), founded in 1929. It operates as a Developer of therapies for treating chronic pain. Esteve has raised an undisclosed amount in funding. The company has 1239 active competitors, including 43 funded and 337 that have exited. Its top competitors include companies like Bayer, Teva Pharmaceuticals and Wockhardt.

Company Details

Developer of therapies for treating chronic pain. Their lead candidate, E-58425 (orally administered therapeutic agent, acts on pain receptors), which is being investigated for severe acute and chronic pain.

Website: www.esteve.com
Social
Email ID: *****@esteve.com
Phone Number: +34 **********

Key Metrics

Founded Year

1929

Location

Barcelona, Spain

Stage

Late Stage

Latest Funding Round

PE, May 17, 2023, $*****

Ranked

99^th among 1239 active competitors

Employee Count

2,461 as on Sep 30, 2026

Investment & Acquisitions

Regis Technologies & 4 more

Similar Companies

Teva Pharmaceuticals & 1463 more

View Esteve's full profile

Esteve has raised funding over 1 round.

Here is the list of recent funding rounds of Esteve:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 17, 2023	5748054	PE	4820203	4893400	8024616	2035013

Access funding benchmarks and valuations. Sign up today!

View details of Esteve's funding rounds and investors

Esteve's employee count trend

Esteve has 2,461 employees as of Sep 26. Here is Esteve's employee count trend over the years:

Uncover Esteve's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Esteve include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of Esteve, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public	Traditional company engaged in manufacturing generics	$500M	Berkshire Hathaway, JANA Partners & 3 others	75/100
3rd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
4th	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
5th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
6th	The Alvogen 2009, Morristown (United States), Acquired	Developer and marketer of pharmaceutical products	$156M	Morgan Stanley, IMM Private Equity & 11 others	69/100
7th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
8th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
9th	Laboratorio Reig Jofre 2000, Barcelona (Spain), Public	Manufacturer of pharmaceutical products and food supplements	-	CDTI, Europa	68/100
10th	Strides Pharma Science 1990, Bengaluru (India), Public	Manufacturer of generic pharmaceutical products and various specialty medical formulations	-	InvAscent, Oman India Joint Investment Fund ... & 2 others	68/100
99th	Esteve 1929, Barcelona (Spain), Late Stage	Developer of therapies for treating chronic pain	-	-	52/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Esteve's competitors? Click here to see the top ones

Esteve has not made any investments yet. Esteve has made 5 acquisitions.

Here is the list of latest three $acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jul 31, 2025	Acquisition	Regis Technologies	1956	Morton Grove (United States)
Jul 12, 2024	Acquisition	HRA Pharma Rare Diseases	1996	Chatillon (France)
Jan 08, 2020	Acquisition	RIEMSER Pharma	2000	Greifswald (Germany)